2018
DOI: 10.15406/htij.2018.06.00187
|View full text |Cite
|
Sign up to set email alerts
|

Preimplantation genetic testing for inherited immunodeficiency

Abstract: Preimplantation genetic testing (PGT) has become a practical tool for at risk couples to avoid affected pregnancies and have a healthy progeny free from genetic and chromosomal disorders. PGT is also an option for stem cell transplantation treatment through combining PGT with preimplantation HLA typing for couples with children affected by congenital disorders, for whom no other alternative therapies are available, such as for congenital immunodeficiency. We present here our experience of 135 PGT cycles perfor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 6 publications
(9 reference statements)
0
2
0
Order By: Relevance
“…However, these two technologies still have limitations in clinical applications ( Fischer and Hacein-Bey-Abina, 2020 ). For some inherited immunodeficiency like SCID, the PGT has become a practical technique for these at-risk couples to avoid affected pregnancies and have a healthy progeny free from genetic and chromosomal disorders ( Rechitsky et al, 2018 ). At present, there is no mature gene therapy program for clinical application for children born with SCID, HSCT from a matched sibling donor is the most effective way.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, these two technologies still have limitations in clinical applications ( Fischer and Hacein-Bey-Abina, 2020 ). For some inherited immunodeficiency like SCID, the PGT has become a practical technique for these at-risk couples to avoid affected pregnancies and have a healthy progeny free from genetic and chromosomal disorders ( Rechitsky et al, 2018 ). At present, there is no mature gene therapy program for clinical application for children born with SCID, HSCT from a matched sibling donor is the most effective way.…”
Section: Discussionmentioning
confidence: 99%
“…At present, there is no mature gene therapy program for clinical application for children born with SCID, HSCT from a matched sibling donor is the most effective way. HLA matched stem cell transplantation improves significantly the outcome of transplantation treatment ( Rechitsky et al, 2018 ). If children born with SCID are treated and protected early by pediatric ICU, they may be able to wait until PGT-M with HLA typing technique helps their family have a sibling who can provide a suitable transplantation donor.…”
Section: Discussionmentioning
confidence: 99%